Lenalidomide/melphalan/dexamethasone in newly diagnosed patients with immunoglobulin light chain amyloidosis: results of a prospective phase 2 study with long-term follow up

Chemotherapy in light chain amyloidosis aims to normalize the involved free light chain in serum, which leads to an improvement, or at least stabilization of organ function in most responding patients. We performed a prospective single center phase 2 trial with 50 untreated patients not eligible for...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Haematologica
Autores principales: Hegenbart, Ute, Bochtler, Tilmann, Benner, Axel, Becker, Natalia, Kimmich, Christoph, Kristen, Arnt V., Beimler, Jörg, Hund, Ernst, Zorn, Markus, Freiberger, Anja, Gawlik, Marianne, Goldschmidt, Hartmut, Hose, Dirk, Jauch, Anna, Ho, Anthony D., Schönland, Stefan O.
Formato: Artigo
Lenguaje:Inglês
Publicado: Ferrata Storti Foundation 2017
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5541875/
https://ncbi.nlm.nih.gov/pubmed/28522573
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2016.163246
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares